Invasive pulmonary aspergillosis post extracorporeal membrane oxygenation support and literature review

Benjamin J Parcell1, Pavan Kumar B C Raju2, Elizabeth M Johnson3

  • 1Department of Medical Microbiology, Ninewells Hospital and Medical School, Dundee, NHS Tayside, DD1 9SY Scotland, UK.

Insights

Extracorporeal membrane oxygenation (ECMO) can lead to invasive pulmonary aspergillosis, a fungal infection. This case highlights successful treatment using antifungal drugs and interferon-gamma.

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Pulmonology

Background:

  • Extracorporeal membrane oxygenation (ECMO) use for reversible pulmonary failure has risen.
  • Nosocomial infections are significant complications during ECMO therapy.
  • Fungal infections are frequently implicated in ECMO-associated complications.

Purpose of the Study:

  • To report a case of invasive pulmonary aspergillosis in a patient undergoing ECMO.
  • To describe the successful treatment of this fungal infection.

Main Methods:

  • Case report of a critically ill patient on ECMO.
  • Diagnosis of invasive pulmonary aspergillosis.
  • Treatment with combination antifungal therapy and interferon-gamma.

Main Results:

  • Successful treatment of invasive pulmonary aspergillosis in an ECMO patient.
  • Demonstration of combination therapy efficacy.

Conclusions:

  • Invasive pulmonary aspergillosis is a potential complication of ECMO.
  • Combination antifungal therapy with interferon-gamma can be effective in treating this condition.

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.8K
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance...
55
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
768
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through...
40